Long-term remission after high-dose chemotherapy followed by auto-SCT as consolidation for intravascular large B-cell lymphoma
Authors:
- 18 August 2014
- journal article
- letter
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 49 (12) , 1543-1544
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 2013
- Central nervous system involvement in intravascular large B‐cell lymphoma: A retrospective analysis of 109 patientsCancer Science, 2010
- Presentation and management of intravascular large B-cell lymphomaThe Lancet Oncology, 2009
- Can Rituximab Change the Usually Dismal Prognosis of Patients With Intravascular Large B-Cell Lymphoma?Journal of Clinical Oncology, 2008
- The addition of rituximab to anthracycline‐based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B‐cell lymphomaBritish Journal of Haematology, 2008
- Retrospective Analysis of Intravascular Large B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy As Reported by the IVL Study Group in JapanJournal of Clinical Oncology, 2008
- Successful treatment of intravascular malignant lymphomatosis with high-dose chemotherapy and autologous peripheral blood stem cell transplantationBone Marrow Transplantation, 2001
- Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosisBone Marrow Transplantation, 2001